Literature DB >> 2269428

Lethal and temperature-sensitive mutations and their suppressors identify an essential structural element in U2 small nuclear RNA.

M Ares1, A H Igel.   

Abstract

U2 snRNA is an essential component of the splicing apparatus in eukaryotic cells. Three possible secondary structures for the highly conserved 5' half of U2 snRNA are consistent with U2 phylogenetic sequence variation. To distinguish among these models and to test the function of U2 structural elements, we made greater than 35 mutations in the yeast U2 snRNA gene. Some of the mutations were designed in pairs so that combinations could be made that would restore base-pairing to differentiate helix requirements from primary sequence requirements. The mutations identify an essential stem-and-loop structure adjacent to the branchpoint interaction region. A conserved complementarity to the loop just upstream of the Sm site and an additional conserved stem-loop are dispensable for U2 function, even in the background of a previously identified large internal deletion. Non-Watson-Crick base appositions at the 53-62 base pair in the essential stem lead to a variety of temperature and KCl-sensitive phenotypes, as well as an accumulation of unspliced precursors in vivo. Chemical structure probing of U2 RNA in vivo reveals that the bulk of U2 in a yeast cell adopts a structure in good agreement with that deduced from genetic results. We suggest that this stem-loop is not a binding site for an intrinsic U2 snRNP protein but may interact with other factors during spliceosome assembly or splicing.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2269428     DOI: 10.1101/gad.4.12a.2132

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  72 in total

1.  Sequences upstream of the branch site are required to form helix II between U2 and U6 snRNA in a trans-splicing reaction.

Authors:  G Ast; T Pavelitz; A M Weiner
Journal:  Nucleic Acids Res       Date:  2001-04-15       Impact factor: 16.971

2.  Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli.

Authors:  P Trang; M Lee; E Nepomuceno; J Kim; H Zhu; F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

3.  Substrate recognition by a eukaryotic RNase III: the double-stranded RNA-binding domain of Rnt1p selectively binds RNA containing a 5'-AGNN-3' tetraloop.

Authors:  R Nagel; M Ares
Journal:  RNA       Date:  2000-08       Impact factor: 4.942

4.  The ATP requirement for U2 snRNP addition is linked to the pre-mRNA region 5' to the branch site.

Authors:  C M Newnham; C C Query
Journal:  RNA       Date:  2001-09       Impact factor: 4.942

5.  Lead(II) as a probe for investigating RNA structure in vivo.

Authors:  Magnus Lindell; Pascale Romby; E Gerhart H Wagner
Journal:  RNA       Date:  2002-04       Impact factor: 4.942

6.  Perturbation of transcription elongation influences the fidelity of internal exon inclusion in Saccharomyces cerevisiae.

Authors:  Kenneth James Howe; Caroline M Kane; Manuel Ares
Journal:  RNA       Date:  2003-08       Impact factor: 4.942

7.  Requirements for U2 snRNP addition to yeast pre-mRNA.

Authors:  X C Liao; H V Colot; Y Wang; M Rosbash
Journal:  Nucleic Acids Res       Date:  1992-08-25       Impact factor: 16.971

8.  Multiple functional domains of human U2 small nuclear RNA: strengthening conserved stem I can block splicing.

Authors:  J Wu; J L Manley
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

9.  Capped mRNA degradation intermediates accumulate in the yeast spb8-2 mutant.

Authors:  R Boeck; B Lapeyre; C E Brown; A B Sachs
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

10.  CUS2, a yeast homolog of human Tat-SF1, rescues function of misfolded U2 through an unusual RNA recognition motif.

Authors:  D Yan; R Perriman; H Igel; K J Howe; M Neville; M Ares
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.